Cancer Biology and Medicine Q1 Unclaimed
Cancer Biology and Medicine is a journal indexed in SJR in Oncology and Cancer Research with an H index of 62. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1350 €. The scope of the journal is focused on cancer genetics, oncology clinical trials, targeted therapy and immunology, cancer and stem cell biology, cancer prevention and epidemiology, cancer biomarkers. It has an SJR impact factor of 1,575 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,575.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -



1350 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,575
SJR Impact factor62
H Index73
Total Docs (Last Year)293
Total Docs (3 years)4508
Total Refs1597
Total Cites (3 years)288
Citable Docs (3 years)4.43
Cites/Doc (2 years)61.75
Ref/DocOther journals with similar parameters
Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1
Compare this journals
Aims and Scope
Best articles by citations
Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study
View moreA new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms
View moreBone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
View moreOvarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms
View moreModulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies
View moreFactors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
View moreExtracranial metastasis of anaplastic oligoastrocytoma
View moreKey questions about the checkpoint blockade-are microRNAs an answer?
View moreChanging paradigm of cancer therapy: precision medicine by next-generation sequencing
View moreEstablishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform
View moreThe oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands
View moreLoss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
View morePrognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment
View moreModified Blumgart anastomosis without pancreatic duct-to-jejunum mucosa anastomosis for pancreatoduodenectomy: a feasible and safe novel technique
View moreDorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels
View moreAdvances in caring for the older cancer patient: a report from the 2015 conference of the International Society of Geriatric Oncology
View moreAggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review
View moreIdentification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
View moreMultidisciplinary team for the diagnosis and treatment of 2 cases of primary intestinal yolk sac tumor
View moreBrain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
View moreCalcium channel a2d1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma
View moreImmunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
View moreThe next generation of cancer management
View moreAttenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice
View more
Comments